-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
HIV-1 infection remains an incurable public health problem
In the present study, researchers conducted a clinical study in which HIV-infected individuals received seven doses of a combination of two broadly neutralizing antibodies, 3BNC117 and 10-1074, over 20 weeks in the presence or absence of ART, Its safety, tolerability and antiviral activity were studied
The study found that the pharmacokinetic profiles of 3BNC117 and 10-1074 were independent of concomitant antiretroviral drugs during viral suppression and did not change after multiple dosing over 20 weeks
Figure virological and pharmacokinetic follow-up of individual participants
These data suggest that antibody administration affects the HIV-1 reservoir, but more studies, larger and longer, are needed to determine the exact effect of antibody immunotherapy on the reservoir
Note: The original text has been deleted
Reference: Gaebler, C.